Navigation Links
Pharma Pricing and Market Access News from HealthEconomics.Com for December 20, 2013
Date:12/20/2013

Ponte Vedra Beach, FL (PRWEB) December 20, 2013

The December 17, 2013 newsletter from HealthEconomics.Com explored whether the growing need for health outcomes studies will lead to increased research and development costs, and potentially strain the already heavily scrutinized drug development budgets. Health Outcomes studies may last 3-6 years and cost as much as $500 million and include between 10,000 and 25,000 patients, according to Forbes.Com’s article by John LaMattina on December 2, 2013. Despite these costs, pharmaceutical outcome studies are in growing demand not just by regulators and payers, but also patients and clinicians, because they provide data on the real value of the medicines as well as more real-world effectiveness data that is not currently addressed by tightly controlled clinical trials.

Another article in the HealthEconomics.Com Newsletter took a look at what healthcare might look like in 2014, based on a recently released publication by the Healthcare Intelligence Network entitled “Healthcare Trends & Forecasts in 2014: Performance Expectations for the Healthcare Industry”. The publication includes a planning tool for executives called the “pyramid of success” utilized to help assess the industry landscape for physicians and hospitals, including the impact of accountable care organizations, medical homes, and other trends. The future for health plans are examined, including the changes in primary care and sector-by-sector impact from the health insurance changes.

Lastly, a White Paper entitled “Counter Brand Revenue Erosion from Generics through Defensive Pricing Strategies” by Cutting Edge Information is examined, in which defensive pharmaceutical pricing strategies are reviewed for use to counter threats from low-priced generic alternatives. The white paper also covers pricing strategies that can be utilized to effectively support future generic competition.

About HealthEconomics.Com (http://www.healtheconomics.com):
A pioneer in the field, HealthEconomics.Com is the global authority in healthcare value and market access. Each day, HealthEconomics.Com compiles the latest news, policy updates, resources, conferences, and jobs for life sciences professionals involved in health economics, outcomes research, market access, and pricing. A trusted resource, HealthEconomics.Com’s comprehensive content is carefully selected by a discerning health economist editor, making it the most visited website for healthcare value and market access in the industry, with visitors encompassing all corners of the globe.

News Media interested in receiving the most current information on healthcare value and market access may obtain a free subscription to HealthEconomics.Com by visiting the site or by clicking on the following link: Subscribe to HealthEconomics.Com Newsletter.

Read the full story at http://www.prweb.com/releases/HealthEconomicsCom/topstories/prweb11440323.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. HealthEconomics.Com Launches Live Streaming Educational Series in HE-Xpo®, the Pharma Industry’s Only Online Virtual Community for Health Economics and Outcomes Research
2. Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics
3. Shimadzu’s New Aggregates Sizer Aggregation Analysis System for Biopharmaceuticals Enables Real-time Quantitative Analysis
4. Americas Pharmaceutical Market Forecasts to 2018
5. Industry Shares, Size, Trend, Analysis, and Forecasts to 2018 Report Available Online by Researchmoz.us
6. Savient Receives Approval From Bankruptcy Court To Sell Substantially All Assets To Crealta Pharmaceuticals
7. The Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells: Emerging Opportunities for the Biopharmaceutical Industry
8. Hart-Scott-Rodino Waiting Period Expires for Shires Acquisition of ViroPharma
9. WavePharma Unveils Proprietary Chitosan-Based Delivery System for Controlled Release of Key Ingredients in Personal Care Products
10. PharmaPoint: Type 2 Diabetes - UK Drug Forecast and Market Analysis to 2022
11. JCB Laboratories Debuts High Tech Monitoring System That Will Further Enhance Patient Safety, Surpass Compounding Pharmacy Standards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... QC , April 20, 2017 /PRNewswire/ - Prometic Life Sciences ... presented new results at the International Liver Congress ("ILC") 2017 ... ("EASL") in Amsterdam on the positive ... a mouse model of obesity and metabolic syndrome. ... According to Dr. Lyne Gagnon, Vice-President ...
(Date:4/20/2017)... and PETACH TIKVAH, Israel , ... a leading developer of adult stem cell technologies for neurodegenerative ... Officer, will present at the Alliance for Regenerative Medicine,s (ARM) ... on Thursday, April 27, 2017 at 09:40 EDT in ... Ralph Kern , MD, MHSc, Chief Medical Officer & Chief ...
(Date:4/19/2017)... ... April 18, 2017 , ... Optofluidics today ... move comes after the company changed focus to making analytical tools for biopharmaceutical ... our new technology,” says CEO Robert Hart. Founders Bernardo Cordovez, Robert Hart and ...
(Date:4/19/2017)... April 19, 2017 A new report published by Allied ... 2014-2022 ," the global market was valued at $6,769 million in 2015, and ... from 2016 to 2022. ... Allied Market Research Logo ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) The cross-flow ...
Breaking Biology Technology:
(Date:3/30/2017)... LOS ANGELES , March 30, 2017  On ... Hack the Genome hackathon at ... This exciting two-day competition will focus on developing health ... experience. Hack the Genome is ... has been tremendous. The world,s largest companies in the ...
(Date:3/27/2017)... ROCKVILLE CENTRE, N.Y. , March 27, 2017 ... by Healthcare Information and Management Systems Society (HIMSS) ... Analytics Outpatient EMR Adoption Model sm . In ... top 12% of U.S. hospitals using an electronic ... recognized CHS for its high level of EMR ...
(Date:3/22/2017)... 2017   Neurotechnology , a provider of ... announced the release of the SentiVeillance 6.0 ... facial recognition using up to 10 surveillance, security ... The new version uses deep neural-network-based facial detection ... utilizes a Graphing Processing Unit (GPU) for enhanced ...
Breaking Biology News(10 mins):